Walgreens quarterly profit beats estimates on strong pharmacy performance

FILE PHOTO: Raindrops hang on a sign for Wall Street outside the New York Stock Exchange in New York. REUTERS/Mike Segar/File Photo

WALGREENS Boots Alliance Inc's quarterly profit beat Wall Street expectations on Tuesday, driven by better-than-expected sales in its retail pharmacy business, sending its shares 3% higher before the opening bell.

The company's U.S. retail pharmacy, its core operations, recorded revenue of $27.6 billion in the second quarter, surpassing analysts' estimate of $26.8 billion, as filling of non-COVID prescriptions offset a hit from falling demand for COVID vaccination.

Administration of COVID vaccines and testing had helped Walgreens offset low non-COVID prescription volumes initially in the pandemic, but the trend has now reversed, with demand for the shots waning in recent quarters, while prescription drug sales rise.

Comparable prescription filled, excluding vaccinations, increased 3.5%, while same-store pharmacy sales rose 4.9% from last year.

Walgreens, one of the largest U.S. pharmacies, has been looking to expand beyond its core business. It spent $5.5 billion in 2021 to take a majority stakes in two smaller healthcare providers, VillageMD and CareCentrix, and also completed its $9 billion acquisition of urgent care provider Summit Health in January.

The Walgreens Health segment saw a sharp increase in revenue to $1.6 billion, driven by VillageMD and Summit Health.

Walgreens said it had incurred a one-time opioid-related charge of $306 million in the quarter, and costs related to the acquisition of Summit Health.

Excluding one-off items, the company reported earnings of $1.16 per share for the quarter ended February, higher than the average analyst estimate of $1.10, according to Refinitiv IBES data. - Reuters

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Walgreens , Wall Street , pharmacy , retail


Next In Business News

Boustead records 1Q net loss of RM62.80mil
Allianz 1Q net profit rises to RM172.69mil
Mida: Malaysia attracts RM71.4bil in approved investments for 1Q
Ringgit ends lower versus greenback on oil price decline, expectation of US rate hike
IJM expects better results in FY24
PNB appoints Raja Arshad as group chairman
Paramount to launch property projects with GDV of RM1.1bil
TNB 1Q net profit soars to RM1bil
AirAsia X posts 1Q net profit of RM328mil as travel rebounds
FBM KLCI ends higher but market breadth stays negative

Others Also Read